Tg Therapeutics Stock Price Prediction
| TGTX Stock | USD 16.76 0.05 0.30% |
Oversold Vs Overbought
54
Oversold | Overbought |
EPS Estimate Next Quarter (0.06) | EPS Estimate Current Year (0.02) | EPS Estimate Next Year 0.59 | Wall Street Target Price 31 | EPS Estimate Current Quarter (0.04) |
Using TG Therapeutics hype-based prediction, you can estimate the value of TG Therapeutics from the perspective of TG Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards TG Therapeutics using TG Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards TGTX using crowd psychology based on the activity and movement of TG Therapeutics' stock price.
TG Therapeutics Short Interest
An investor who is long TG Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about TG Therapeutics and may potentially protect profits, hedge TG Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 13.743 | Short Percent 0.2454 | Short Ratio 8.05 | Shares Short Prior Month 34.3 M | 50 Day MA 15.6266 |
TG Therapeutics Hype to Price Pattern
Investor biases related to TG Therapeutics' public news can be used to forecast risks associated with an investment in TGTX. The trend in average sentiment can be used to explain how an investor holding TGTX can time the market purely based on public headlines and social activities around TG Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of TG Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about TG Therapeutics.
TG Therapeutics Implied Volatility | 71.44 |
TG Therapeutics' implied volatility exposes the market's sentiment of TG Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if TG Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that TG Therapeutics stock will not fluctuate a lot when TG Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in TG Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying TGTX because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
TG Therapeutics after-hype prediction price | USD 16.81 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current TGTX contract
Based on the Rule 16, the options market is currently suggesting that TG Therapeutics will have an average daily up or down price movement of about 4.47% per day over the life of the 2024-06-14 option contract. With TG Therapeutics trading at USD 16.76, that is roughly USD 0.75 . If you think that the market is fully incorporating TG Therapeutics' daily price movement you should consider acquiring TG Therapeutics options at the current volatility level of 71.44%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
TGTX |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of TG Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
TG Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of TG Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in TG Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of TG Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
TG Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting TG Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on TG Therapeutics' historical news coverage. TG Therapeutics' after-hype downside and upside margins for the prediction period are 13.67 and 19.95, respectively. We have considered TG Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
TG Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of TG Therapeutics is based on 3 months time horizon.
TG Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as TG Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading TG Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with TG Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.22 | 3.14 | 0.12 | 0.06 | 7 Events / Month | 3 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
16.76 | 16.81 | 0.00 |
|
TG Therapeutics Hype Timeline
TG Therapeutics is at this time traded for 16.76. The entity has historical hype elasticity of -0.12, and average elasticity to hype of competition of 0.06. TGTX is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.22%. %. The volatility of related hype on TG Therapeutics is about 1243.56%, with the expected price after the next announcement by competition of 16.82. About 59.0% of the company shares are owned by institutional investors. The company had not issued any dividends in recent years. TG Therapeutics had 100:5625 split on the 30th of April 2012. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days. Check out TG Therapeutics Basic Forecasting Models to cross-verify your projections.TG Therapeutics Related Hype Analysis
Having access to credible news sources related to TG Therapeutics' direct competition is more important than ever and may enhance your ability to predict TG Therapeutics' future price movements. Getting to know how TG Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how TG Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ELYM | Eliem Therapeutics | 0.08 | 8 per month | 3.70 | 0.20 | 20.98 | (7.38) | 86.31 | |
| ANEB | Anebulo Pharmaceuticals | (0.03) | 6 per month | 0.00 | (0.03) | 5.71 | (6.52) | 31.09 | |
| GLUE | Monte Rosa Therapeutics | (0.03) | 10 per month | 0.00 | (0.08) | 7.66 | (8.78) | 31.83 | |
| EWTX | Edgewise Therapeutics | 0.99 | 7 per month | 3.79 | 0.02 | 5.22 | (5.89) | 17.83 |
TG Therapeutics Additional Predictive Modules
Most predictive techniques to examine TGTX price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for TGTX using various technical indicators. When you analyze TGTX charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About TG Therapeutics Predictive Indicators
The successful prediction of TG Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as TG Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of TG Therapeutics based on analysis of TG Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to TG Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to TG Therapeutics's related companies. | 2023 | 2024 (projected) | Dividend Yield | 4.28E-4 | 4.06E-4 | Price To Sales Ratio | 10.38 | 9.86 |
Story Coverage note for TG Therapeutics
The number of cover stories for TG Therapeutics depends on current market conditions and TG Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that TG Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about TG Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
TG Therapeutics Short Properties
TG Therapeutics' future price predictability will typically decrease when TG Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of TG Therapeutics often depends not only on the future outlook of the potential TG Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. TG Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 148.5 M | |
| Cash And Short Term Investments | 217.5 M |
Additional Tools for TGTX Stock Analysis
When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.